204 related articles for article (PubMed ID: 8209101)
1. [Chronic renal insufficiency and secondary hyperparathyroidism in rats. Biochemical and histological evaluation].
Virgós MJ; Menéndez-Rodríguez P; Serrano M; González-Carcedo A; Braga S; Cannata JB
Rev Esp Fisiol; 1993 Dec; 49(4):241-7. PubMed ID: 8209101
[TBL] [Abstract][Full Text] [Related]
2. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
[TBL] [Abstract][Full Text] [Related]
3. Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats.
Oste L; Behets GJ; Dams G; Bervoets AR; Marynissen RL; Geryl H; Van Hoof VO; De Broe ME; D'Haese PC
Ren Fail; 2007; 29(1):1-12. PubMed ID: 17365904
[TBL] [Abstract][Full Text] [Related]
4. A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism.
Bank N; Su WS; Aynedjian HS
J Clin Invest; 1978 Apr; 61(4):884-94. PubMed ID: 659581
[TBL] [Abstract][Full Text] [Related]
5. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.
Jablonski G; Danielsen CC; Mosekilde L; Gordeladze JO
Calcif Tissue Int; 1994 Oct; 55(4):281-7. PubMed ID: 7820779
[TBL] [Abstract][Full Text] [Related]
6. Secondary hyperparathyroidism in chronic renal failure.
Wills MR; Savory J
Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
[TBL] [Abstract][Full Text] [Related]
8. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.
Ishii H; Wada M; Furuya Y; Nagano N; Nemeth EF; Fox J
Bone; 2000 Feb; 26(2):175-82. PubMed ID: 10678413
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
Madsen S
Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
[No Abstract] [Full Text] [Related]
11. Renal osteodystrophy: past and future.
Slatopolsky E; Lopez-Hilker S; Dusso A; Brown A; Delmez J; Martin K
Contrib Nephrol; 1990; 78():38-45; discussion 45-6. PubMed ID: 2225842
[No Abstract] [Full Text] [Related]
12. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.
Slatopolsky E; Rutherford WE; Martin K; Hruska K
Adv Exp Med Biol; 1977; 81():467-75. PubMed ID: 899937
[No Abstract] [Full Text] [Related]
13. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
[TBL] [Abstract][Full Text] [Related]
14. [Renal osteodystrophy: role of vitamin D and parathyroid hormone].
Drüeke T; Ulmann A
Nouv Presse Med; 1979 May; 8(23):1901-3. PubMed ID: 223122
[No Abstract] [Full Text] [Related]
15. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?
Behets GJ; Dams G; Vercauteren SR; Damment SJ; Bouillon R; De Broe ME; D'Haese PC
J Am Soc Nephrol; 2004 Aug; 15(8):2219-28. PubMed ID: 15284308
[TBL] [Abstract][Full Text] [Related]
16. Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.
Geng Z; Monier-Faugere MC; Bauss F; Malluche HH
Clin Nephrol; 2000 Jul; 54(1):45-53. PubMed ID: 10939756
[TBL] [Abstract][Full Text] [Related]
17. Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease.
Jara A; Felsenfeld AJ; Bover J; Kleeman CR
Kidney Int; 2000 Sep; 58(3):1023-32. PubMed ID: 10972667
[TBL] [Abstract][Full Text] [Related]
18. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
Fournier A; Bordier P; Weil B; Safar M; Idatte JM
Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047
[No Abstract] [Full Text] [Related]
19. Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7.
González EA; Lund RJ; Martin KJ; McCartney JE; Tondravi MM; Sampath TK; Hruska KA
Kidney Int; 2002 Apr; 61(4):1322-31. PubMed ID: 11918739
[TBL] [Abstract][Full Text] [Related]
20. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.
Tamagaki K; Yuan Q; Ohkawa H; Imazeki I; Moriguchi Y; Imai N; Sasaki S; Takeda K; Fukagawa M
Nephrol Dial Transplant; 2006 Mar; 21(3):651-9. PubMed ID: 16311258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
